Century Therapeutics
IPSC----
Century Therapeutics (IPSC)
Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological mal...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Century Therapeutics Analyst Rating
View MoreForecast & Rating
Jun 9, 2026Price forecast
$4.75125.12%
Forecast & RatingBuy
5analysts
- Strong buy60.00%
- Buy20.00%
- Hold20.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 9 at 07:01 AM
Century Therapeutics to present CNTY-813 type 1 diabetes preclinical data at EASD 2026
- Unusual Whales · Jun 8 at 03:06 PM
New CNTY-813 Preclinical Data Demonstrate Durable Glucose Control, Immune Evasion Under Alloimmune Pressure, and Scalable Manufacturing at ADA 2026
- benzinga_article · Jun 8 at 07:04 AM
Graham, Appian And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- benzinga_article · May 27 at 01:06 PM
Century Therapeutics shares are trading higher after Mizuho initiated coverage on the stock with an Outperform rating and announced an $8 price target.
- TradingView · May 14 at 07:23 AM
Cor appoints Brent Pfeiffenberger to board as independent director
- Earnings Watch · May 13 at 07:11 AM
Century Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0
